47.71
0.44%
0.21
시간 외 거래:
47.71
Sanofi Adr 주식(SNY)의 최신 뉴스
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
Communiqué de presse - GlobeNewswire Inc.
10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar
Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug - Investor's Business Daily
What Did We Find About Insider Trading At Sanofi ADR (NASDAQ: SNY)? - Stocks Register
Weekly Upgrades and Downgrades - InvestorPlace
Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - MSN
Top-3 International Stocks Beating Their U.S. Peers for Dividend Earnings - TheStreet
Novo Nordisk and AstraZeneca top 2025 drug picks for US investment bankread why - Proactive Investors USA
Why Sanofi (SNY) Is One of the Best ADR Stocks to Invest in? - Insider Monkey
12 Best ADR Stocks To Invest In According to Analysts - Insider Monkey
T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.
How Robert F. Kennedy Jr. Will Bring Major Uncertainties to U.S. Healthcare - Barron's
Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes
Here’s Why Mastercard Incorporated (NYSE: MA) Is An Attractive Investment Right Now - Stocks Register
Sanofi (SNY) Stock Price, News, Quote & History - Yahoo Finance
16 New 4-Star Stocks - Morningstar
Biggest stock movers Monday: DJT, crypto stocks, and more - MSN
자본화:
|
볼륨(24시간):